Department of Anatomy and Embryology, Leiden University Medical Centre, Leiden, the Netherlands.
The Center for Stem Cell Biology, Developmental Biology Program, Sloan Kettering Institute for Cancer Research, New York, NY, USA.
Nat Protoc. 2021 Apr;16(4):2213-2256. doi: 10.1038/s41596-021-00497-2. Epub 2021 Mar 26.
Tissue-like structures from human pluripotent stem cells containing multiple cell types are transforming our ability to model and understand human development and disease. Here we describe a protocol to generate cardiomyocytes (CMs), cardiac fibroblasts (CFs) and cardiac endothelial cells (ECs), the three principal cell types in the heart, from human induced pluripotent stem cells (hiPSCs) and combine them in three-dimensional (3D) cardiac microtissues (MTs). We include details of how to differentiate, isolate, cryopreserve and thaw the component cells and how to construct and analyze the MTs. The protocol supports hiPSC-CM maturation and allows replacement of one or more of the three heart cell types in the MTs with isogenic variants bearing disease mutations. Differentiation of each cell type takes ~30 d, while MT formation and maturation requires another 20 d. No specialist equipment is needed and the method is inexpensive, requiring just 5,000 cells per MT.
源自人类多能干细胞的类组织结构包含多种细胞类型,正在改变我们对人类发育和疾病建模和理解的能力。在这里,我们描述了一种从人诱导多能干细胞(hiPSC)生成心肌细胞(CMs)、心脏成纤维细胞(CFs)和心脏内皮细胞(ECs)这三种心脏主要细胞类型的方案,并将它们组合成三维(3D)心脏微组织(MT)。我们介绍了如何分化、分离、冷冻保存和解冻细胞,以及如何构建和分析 MT 的详细信息。该方案支持 hiPSC-CM 成熟,并允许用携带疾病突变的同基因变体替换 MT 中三种心脏细胞类型中的一种或多种。每种细胞类型的分化大约需要 30 天,而 MT 的形成和成熟则需要另外 20 天。该方法不需要专门的设备,且成本低廉,每个 MT 仅需要 5000 个细胞。